Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Alert for Zomig-ZMT®: As of August 1, 2013, Zomig-ZMT® orally disintegrating tablets and Zomig® tablets will no longer be part of the Plan’s preferred drug list (Express Scripts’ formulary), due to the availability of a generic equivalent. As a result, this medication will be more expensive. If you continue to purchase this medication on or after August 1, 2013 you will pay a higher non-preferred brand name copayment, subject to the below-mentioned ancillary charge if you request the brand name. Below is an illustration of the cost difference in the brand name non-formulary and the lower cost generic alternative: Drug Type Generic medication Non-preferred brand name or (non-formulary drug) Drug Name Zolmitriptan orally disintegrating tablet Zolmitriptan tablet Zomig-ZMT® orally disintegrating tablet Zomig® tablet Copayment for up to a 34-day supply at a network pharmacy after you meet your deductible $5 50% of the medication cost Minimum copayment: $50 Maximum copayment: $150 For more details on the Citigroup Prescription Drug Plan benefit, visit Citi Benefits Online at www.citibenefitsonline.com, select “What’s Covered?,” followed by “Health Care” then “Prescription drugs” and “Prescription drug benefits at a glance”. The newly available generic preferred medication is a safe, effective alternative to your current medication and will cost less than the one you’re currently taking. We realize only you and your doctor can decide which medications are right for you. If you have used Zomig ® or Zomig-ZMT® in the past 5 months you will receive a communication in the mail with more information.